Additionally, miR-34a and TP53 can synergistically inhibit tumor initiation, invasion and metastasis in mouse models of CRC by increasing the levels of target proteins IL6R and PAI1 (Öner et al., 2018). This evidence concerns the gene SERPINE1 and colorectal carcinoma.